Girihlet

Developer of a platform targeting the immune system and mitochondria to understand and fight disease

placeNew York City, New York, United States calendar_todayFounded 2014 groups2 employees language girihlet.com

Registered entities

Investor mix

4 investors on record; lead investors include IndieBio.

Investor typeCountShare
Venture capital250%
Accelerator & incubator250%
Coming soon